Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
- Posted on August 18, 2025
- By CNBC
- 2 Views
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
Patients can pay $499 in cash per month for three dose sizes of Ozempic through the company's direct-to-consumer pharmacy and GoodRx, among other platforms.
